Method of quantifying cardiac fibrillation using wavelet transform

• US 5,439,483 A
• Filed: 10/21/1993
• Issued: 08/08/1995
• Est. Priority Date: 10/21/1993
• Status: Expired due to Term

• Current Assignee: Pacesetter Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Ventritex Incorporated (Abbott Laboratories Incorporated)
• Inventors: Duong-Van, Minh
• Primary Examiner(s): Kamm, William E.
• Assistant Examiner(s): Parker, Marianne
• Application Number:
  US08/139,953
• Time in Patent Office: 656 Days
• Field of Search: 128/700, 128/702, 128/705, 607/4, 607/5, 607/7
• US Class Current: 607/5
• CPC Class Codes: A61N 1/3956 Implantable devices for applying electric shocks to the heart, e.g. for cardioversion

Abstract

The present invention provides a system and method for characterizing cardiac fibrillation using wavelet transforms. By characterizing the seriousness of a fibrillation episode, a defibrillation shock may be delivered to the heart with less excess energy than conventional ICDs. A wavelet transform is performed on a digitized ECG using a second derivative weight function and the results are analyzed for missing "peaks" in the data. The more serious the fibrillation, the more peaks will be missing from the data. This information may then used to modify the voltage of the defibrillation shocks as a function of the seriousness of the fibrillation.

Claims

1. A method of quantifying cardiac fibrillation comprising the steps of:

(a) sensing the electrical signals of a patient'"'"'s heart to provide an ECG signal;

(b) detecting the presence of a fibrillation event;

(c) performing a wavelet transform on the fibrillation event in said ECG signal; and

(d) analyzing the resultant wavelet transform by searching for an absence of signal spikes to characterize the fibrillation event.

2. The method of claim 1 and further including the step of generating an output to modify a voltage to which one or more high voltage capacitors of an implantable defibrillator are charged based on a detected number of missing spikes.

3. The method of claim 1 wherein said wavelet transform is characterized by a function which is a second derivative of said ECG signal.

4. The method of claim 3 wherein a spectral function of said ECG signal is generated by performing said wavelet transform using an equation:

space="preserve" listing-type="equation">S(s,T)=∫

f(t)(1/√

s)W[(t-T)/s]dt

where S(s,T) is a spectral function, f(t) is an ECG time series during fibrillation, T is a zoom point of the time series, s is a scale factor, and W[(t-T)/s] is the second derivative function.

5. The method of claim 1 and further including the step of digitizing said ECG signal.

6. A device for characterizing fibrillation of a patient'"'"'s heart comprising:

means for sensing an ECG signal from said patient'"'"'s heart;

means for performing a wavelet transform on said ECG signal; and

means for analyzing a resultant transform for an absence of characteristic spikes.

7. A device according to claim 6 wherein said means for analyzing and said means for performing a wavelet transform include a microprocessor.

8. A method for characterizing fibrillation in an ECG signal to determine a level of seriousness of an arrhythmia comprising the steps of:

(a) sensing an ECG signal from a patient'"'"'s heart;

(b) performing a wavelet transform characterized by a second derivative function for a predetermined frequency range on a series of QRS complexes from the ECG of the patient during fibrillation to provide a resultant transform;

(c) determining a number of missing peaks in the resultant transform; and

(d) characterizing the seriousness of the fibrillation based on the number of missing peaks.

9. The method of claim 8 and further including the step of digitizing said ECG signal.

10. An implantable defibrillator system comprising:

electrode means adapted to be coupled to a patient'"'"'s heart for use in sensing electrical signals from said patient'"'"'s heart;

sensing means having an input connected to said electrode means for sensing analog ECG heart signals;

analog-to-digital means for converting the analog ECG heart signal into a digitized ECG heart signal; and

fibrillation characterizing means for characterizing a level of severity of a fibrillation signal including means for performing a wavelet transform on said digitized ECG signal to provide a resultant transform and for analyzing the resultant transform for an absence of characteristic peaks.